Is ANIX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ANIX. It does not provide personalized investment advice.

ANIX (Anixa Biosciences, Inc.) Stock Analysis - Financials

Anixa Biosciences, Inc. (ANIX) is a publicly traded Healthcare sector company. As of October 20, 2026, ANIX trades at $2.65 with a market cap of $92.82M and a P/E ratio of -8.57. ANIX moved -1.87% today. Year to date, ANIX is -17.41%; over the trailing twelve months it is -36.34%. Its 52-week range spans $2.32 to $5.46. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces ANIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ANIX's key financials?

ANIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ANIX recently traded at $2.65. Market cap is $92.82M. P/E ratio is -8.57. Revenue is $0.

ANIX Key Metrics

Key financial metrics for ANIX
Metric	Value
Price	$2.65
Market Cap	$92.82M
P/E Ratio	-8.57
EPS	$-0.34
Dividend Yield	0.00%
52-Week High	$5.46
52-Week Low	$2.32
Volume	85.70K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-11.03M
Gross Margin	0.00%

ANIX Analyst Consensus

1 analysts cover ANIX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.

Common questions about ANIX

What are ANIX's key financials?: ANIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ANIX recently traded at $2.65. Market cap is $92.82M. P/E ratio is -8.57. Revenue is $0.
Is ANIX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ANIX. It does not provide personalized investment advice.